TERENCE W FRIEDLANDER
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SAN FRANCISCO, CA NPI 1215134267
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CA Astellas Pharma Europe Ltd All categories
General Payments — all program years on this page
$218,714.48
- Category: General Payments
- Program years: PY2018–2024
- Record count: 168
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $112,141.49 across 48 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $69,166.00 | 19 |
| Travel and Lodging | $26,899.83 | 13 |
| Honoraria | $9,800.00 | 3 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,306.99 | 3 |
| Food and Beverage | $968.67 | 10 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma Europe Ltd | $45,633.38 | 10 |
| Astellas Pharma Inc | $20,630.87 | 11 |
| PFIZER INC. | $10,041.87 | 6 |
| EMD Serono, Inc. | $8,520.00 | 1 |
| ABBVIE INC. | $8,100.00 | 2 |
| E.R. Squibb & Sons, L.L.C. | $4,868.92 | 5 |
| Gilead Sciences, Inc. | $4,851.69 | 4 |
| EMD Serono Research & Development Institute, Inc. | $3,800.00 | 1 |
| Merck Sharp & Dohme Corporation | $2,057.86 | 3 |
| Acerta Pharma LLC | $1,759.00 | 2 |
| Samsung Bioepis Co., Ltd. | $1,040.00 | 1 |
| Janssen Scientific Affairs, LLC | $817.50 | 1 |
| Genentech USA, Inc. | $20.40 | 1 |
By program year
Records — PY2024 (48)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.